Levaquin and Cipro are two of the most popular named insurance settlement beneficiaries. Both were awarded a very substantial amount, that is to say about $1.75 million each, and it is no wonder they have become so popular with insurance companies. Cipro was paid by what is called a “couple of million” settlement, and Levaquin was not paid by the same amount but in a much larger sum. These settlements are quite controversial because while they are generally larger than most settlements, they are not the biggest.

Levaquin and Cipro Lawsuit

Levaquin and Cipro lawsuit funding has recently become a subject of public controversy, and many people question the legality of such funding. Insurance attorneys do not generally fund lawsuits; instead they pursue a contingency fee basis, which means that they only get their share if the lawsuit is successful. It should be noted that many such cases are successful and the plaintiff is able to receive a large portion of his or her award. Nevertheless, this still does not prevent insurance attorneys from pursuing these lawsuits in order to recover their legal fees.

Such lawsuits can take many forms. Some of the more popular include mesothelioma, which are caused by long-term exposure to asbestos, and breast cancer, which can develop in women who were exposed to harmful chemical. Some of the more frivolous lawsuits have also been brought against chemical manufacturers and other manufacturers of products that allegedly contributed to the development of cancer.

In Levaquin and Cipro lawsuit funding cases, there are typically two parties, the plaintiff and the defendant.

The plaintiff’s attorney generally files the lawsuit and obtains a settlement. Once the settlement has been reached, the attorney returns to work on a contingency fee basis, meaning that he or she only receives a percentage of the actual amount. Some plaintiffs do not want to wait for a favorable ruling before proceeding with a lawsuit. Others believe that the plaintiff’s attorney will have a conflict of interest if he or she advances the case before the defendant. They also may not have sufficient knowledge to assess the strength of their case.

When both sides come to an agreement on a settlement, the lawsuit is submitted to a judge.

If the judge approves, the plaintiff and his or her attorney will both be paid a portion of the settlement. However, if the judge denies the settlement, the case must be re-opened with a new attorney. If the plaintiff’s attorney is successful in getting the settlement, the money paid to him or her will be returned to the plaintiff. If the case does not resolve satisfactorily within a reasonable time, a motion to dismiss is made, which directs the court to enter judgment in favor of the defendant.

In Levaquin and Cipro lawsuit funding, the plaintiff often has to face long delays.

He or she has to submit numerous detailed financial documents before being approved for funding. This can be very frustrating for people who are not familiar with the complex laws governing litigation. Many plaintiffs do not pursue settlement because they believe that they will have difficulty finding funding. Others simply give up hope of making any money.

By Ricky

Leave a Reply

Your email address will not be published. Required fields are marked *